Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone treatment in acute interstitial nephritis
2017-000992-10Phase 4Active
- Sponsor
- University Clinic for Nephrology (Skopje)
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of prednisolone in Acute tubulointerstitial nephritis (ATIN) and tubulointerstitial nephritis (TIN), sponsored by University Clinic for Nephrology (Skopje). Primary endpoint: Primary: eGFR at 3 months. Started Apr 2017; status: active.
02
Drugs
prednisolone
03
Conditions
Acute tubulointerstitial nephritis (ATIN)tubulointerstitial nephritis (TIN)
Beyond the preview
Go deeper on 2017-000992-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000992-10.